Hunan Jingfeng Pharmaceutical Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Hunan Jingfeng Pharmaceutical Co., Ltd. was listed in December 2014. The company adheres to the concept of "consolidating the foundation, technological innovation, and sustainable development", and adheres to the path of industrialization of high-end characteristic generic drugs that is in line with international standards. We currently have 22 wholly-owned and holding subsidiaries located in Shanghai, Guizhou, Liaoning, Jiangsu, and Hainan. The company's main business products cover major disease fields such as cardiovascular and cerebrovascular diseases, oncology, orthopedics, pediatrics, and gynecology. It has core varieties such as "Baisaitong Shenxiong Glucose Injection", "Jingang Elemene Emulsion Injection", "Baibei Sodium Hyaluronate Injection", "Tirofiban Hydrochloride Sodium Chloride Injection", as well as characteristic traditional Chinese medicine products such as "Xinnaoning Capsules", "Children's Spring Revitalization Granules", "Tongdi Capsules", and "Lemai Pills", And products such as "Lansoprazole for Injection", "Omeprazole Sodium for Injection", "Pantoprazole Sodium for Injection", "Gemcitabine Hydrochloride for Injection", "Pemetrexed Disodium for Injection", "Irinotecan Hydrochloride Injection", "Oxaliplatin for Injection", "Fludarabine Phosphate for Injection", "Adenosine Monophosphate for Injection", and "Clindamycin Phosphate for Injection". Received honorary titles such as "2016 China's Top 100 Pharmaceutical Industry", "2016 China's Top 100 Pharmaceutical Industry", "2016 China's Top 100 Manufacturing Listed Companies Creating Value", "2017 China's Most Influential Pharmaceutical Enterprise 100", "2018 China's Top 100 Pharmaceutical Industry 28", and "2019 China's Listed Pharmaceutical Enterprise Chemical Comprehensive Strength Ranking 46th". |
| Headquarter | Changde |
| Establish Date | 12/18/1998 |
| Listed Code | 000908.SZ |
| Listed Date | 2/3/1999 |
| Chairman | Ye Xiangwu. |
| CEO | Ye Xiangwu. |
| Website | www.jfyiyao.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
